Meeting
2022 ASCO Annual Meeting
Effect of neoadjuvant versus adjuvant chemotherapy on ipsilateral breast tumor recurrence after breast-conserving surgery and whole-breast irradiation.
Authors
Jong-Ho Cheun
Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, South Korea
Jong-Ho Cheun , Hong-Kyu Kim , Han-Byoel Lee , Hyeong-Gon Moon , Wonshik Han
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Neoadjuvant Therapy
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 604)
DOI
10.1200/JCO.2022.40.16_suppl.604
Abstract #
604
Poster Bd #
375
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, hormone receptor+, HER2-, RS ≤18 breast cancer.
First Author: Julia R. White
Poster
2022 ASCO Annual Meeting
Real-world clinical outcomes in patients with local/regional HER2-low breast cancer: An NCDB analysis.
First Author: Changchuan Jiang
Poster
2019 ASCO Annual Meeting
The prognostic role of progesterone receptor in patients with rapidly proliferating, hormone receptor-positive early breast cancer.
First Author: Sara Bravaccini
Poster
2018 ASCO Annual Meeting
Persistence of circulating tumor cells in high risk early breast cancer patients five years after adjuvant chemotherapy and late recurrence: Results from the adjuvant SUCCESS A trial.
First Author: Wolfgang Janni